drug
dotinurad
Phase 3updated 3mo agoby Crystalys Therapeutics Inc
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying dotinurad
- phase3A Study of Dotinurad Versus Allopurinol in Participants With Gout
- phase3A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
- phase2A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
- phase3A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout
- phase2Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia
- phase1A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants
News(3)
- Crystalys nets $130M more to push gout drug through late-stage testsThe startup has a broad global development program underway — and the support of more than 20 investment firms — for a treatment that’s approved in many Asian countries but isn’t yet available in t…biopharma_dive · 20d ago
- Crystalys mines $130M series B to push gout drug through phase 3Crystalys Therapeutics has raised $130 million in series B financing to advance the development of its gout drug dotinurad and prepare for a potential commercial launch.fiercebiotech · 21d ago
- Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90MThe Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.fiercebiotech · 7mo ago
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that